
Da Zhang
Articles
-
Apr 22, 2024 |
arxiv.org | Da Zhang |Xuelong Li
-
Feb 4, 2024 |
onlinelibrary.wiley.com | Da Zhang |Rong Gu |Yunxu Yang |Jiaqi Ge
Conflict of interest The authors declare no conflict of interest. Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
-
Jan 16, 2024 |
onlinelibrary.wiley.com | Rong Gu |Da Zhang |Sheng Zhu |Jinting Xu
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202310747-sup-0001-SuppMat.pdf5.8 MB Supporting Information References 1a) , , , , , , , , Nat. Energy 2017, 2, 17108; b) , , , , , , , Adv. Mater. 2022, 34, 2107899. 2a) , , Adv. Energy Mater. 2020, 10, 2001972; b) , , , , , , , , Energy Environ. Sci. 2022, 15, 1711; c) , , , , , , , , , , ACS Appl. Mater. Interfaces 2017, 9, 18826.
-
Jan 15, 2024 |
pericles.pericles-prod.literatumonline.com | Rong Gu |Da Zhang |Sheng Zhu |Jinting Xu
Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description adfm202310747-sup-0001-SuppMat.pdf5.8 MB Supporting Information References 1a) , , , , , , , , Nat. Energy 2017, 2, 17108; b) , , , , , , , Adv. Mater. 2022, 34, 2107899. 2a) , , Adv. Energy Mater. 2020, 10, 2001972; b) , , , , , , , , Energy Environ. Sci. 2022, 15, 1711; c) , , , , , , , , , , ACS Appl. Mater. Interfaces 2017, 9, 18826.
-
Jun 9, 2023 |
nature.com | Da Zhang
AbstractOncolytic virotherapy can lead to tumor lysis and systemic anti-tumor immunity, but the therapeutic potential in humans is limited due to the impaired virus replication and the insufficient ability to overcome the immunosuppressive tumor microenvironment (TME).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →